Ondra Health
About
Semaglutide Tirzepatide
How It Works FAQ Blog Get Started
Patient Portal
About
Semaglutide Tirzepatide
How It Works FAQ Blog
Get Started Patient Portal
⏱ 7 min read 🏷 Medication Guides

How Long Does Semaglutide Take to Work? A Week-by-Week Timeline

Semaglutide starts working almost immediately — but "working" means different things at different stages. Appetite changes come first. Visible weight loss follows weeks later. Maximum effect builds over months. Here's an evidence-based breakdown of what to expect and when, so you know what's normal and what's not.

← Back to all articles

Key takeaways

✔

Semaglutide reaches peak concentration 1–3 days after your first injection. Appetite suppression begins within the first week for most patients.

✔

Measurable weight loss typically starts at weeks 4–8, with the most substantial progress between months 3–6 as dosing increases.

✔

The STEP 1 clinical trial (NEJM, 2021) showed an average weight loss of 14.9% over 68 weeks — roughly 2% per month in the first six months.

✔

The starting dose (0.25mg) is not a therapeutic dose — it's designed to minimize side effects. Don't judge semaglutide's effectiveness until you're at a meaningful dose.

✔

Weight loss slows but continues past month 6. A plateau is normal — it signals your body adapting, not the medication failing.

Week 1: your body adjusts

After your first injection, semaglutide is absorbed into your bloodstream and reaches peak concentration within 1 to 3 days. The medication begins binding to GLP-1 receptors in your gut and brain almost immediately.

What most patients notice in week 1:

Appetite changes (very common)

Reduced hunger, feeling full sooner during meals, quieter "food noise" — the background mental preoccupation with food that many patients describe as one of the most meaningful early effects. Some patients notice this within 48 hours. Others take a week or two.

GI adjustment (common)

Nausea, mild stomach discomfort, or changes in digestion are common in the first 1–2 weeks as your body adjusts to semaglutide slowing gastric emptying. These typically subside. If severe, contact your provider.

Visible weight loss (not yet)

The starting dose of 0.25mg is below the therapeutic threshold for most patients. Its purpose is tolerability, not weight loss. Don't expect the scale to move significantly in week 1.

Weeks 2–4: appetite suppression takes hold

As the medication reaches steady state — meaning your body has consistent levels of semaglutide from weekly injections — the appetite-suppressing effects strengthen. Most patients notice they're eating smaller portions without feeling deprived, and food cravings diminish noticeably.

In the STEP 1 trial, participants had lost an average of over 2% of body weight by week 4 — roughly 4 lbs for a 200-lb person. Some patients lose more, some less.

What's normal at weeks 2–4

Consistent appetite reduction. Possibly 1–4 lbs of early weight loss. Continued GI adjustment that is usually milder than week 1. Some patients have no side effects at all by this point.

What to discuss with your provider

Persistent nausea interfering with eating or daily life. No appetite change whatsoever after 2 weeks — your provider may adjust your titration schedule.

Months 1–3: the titration ramp

This is where semaglutide starts to show its real effect. Your dose is increasing monthly — from 0.25mg to 0.5mg, then to 1mg — and each step up amplifies appetite suppression and accelerates weight loss.

Clinical data from the STEP 1 trial shows participants lost approximately 5–10% of body weight by month 3. Real-world data from a 2025 SHAPE study in PMC comparing semaglutide and tirzepatide in real clinical practice confirmed clinically meaningful weight loss for both medications at one year.

Month
Typical Dose
Avg. Weight Loss (Clinical Trial)
Month 1
0.25mg
~2% body weight
Month 2
0.5mg
~4% body weight
Month 3
1mg
~6–8% body weight
Month 4
1.5mg
~9–11% body weight
Month 5+
2.4–2.5mg
~12–15%+ body weight

Averages from the STEP 1 clinical trial (NEJM, 2021). Individual results vary. Dose schedule is illustrative — your provider determines your titration.

Months 3–6: the most significant progress window

For most patients, months 3 through 6 represent the highest rate of weight loss. You're at or approaching your full therapeutic dose, your body has adapted to the medication, and the combination of reduced appetite and caloric deficit compounds over time.

The STEP 5 trial (Nature Medicine, 2022), which followed patients for 104 weeks, confirmed that weight loss was sustained over 2 years — not just a short-term effect.

What the clinical data shows at 6 months

Patients on semaglutide 2.4mg lost an average of 10–15% of their starting body weight by month 6 in STEP trial data. For a 220-lb person, that represents 22–33 lbs. Real-world results vary; some patients lose significantly more, others less.

Health markers that often improve alongside weight

Blood pressure, fasting blood sugar, cholesterol, and inflammatory markers frequently improve in parallel with weight loss. The SELECT cardiovascular trial, published in Nature Medicine (2024), showed semaglutide reduced major cardiovascular events by 20% in high-risk patients.

Months 6–12+: plateau, maintenance, and what comes next

Weight loss naturally slows after month 6. This isn't the medication failing — it's biology. As your body weight decreases, your basal metabolic rate adjusts downward, requiring fewer calories. The rate of loss slows, but for most patients, loss continues through the full treatment period.

The STEP 1 trial reached an average of 14.9% weight loss at 68 weeks (about 17 months). Individual results ranged widely — some participants lost over 20%, some plateaued at 8–10%.

If you plateau before reaching your goal

A plateau at your current dose is a signal to discuss with your provider — not to stop. Options include a dose adjustment, lifestyle changes, or a medication review. Plateaus are a normal part of the weight loss process with any intervention.

What happens if you stop

Studies show that most patients regain a meaningful portion of lost weight within 1 year of stopping semaglutide if lifestyle habits aren't maintained. The STEP 4 trial (JAMA, 2021) showed participants who discontinued semaglutide regained about two-thirds of lost weight within a year. Tapering and maintenance planning with your provider matters.

Why some people see results faster than others

Individual variation in response to semaglutide is real and clinically documented. Several factors influence how quickly the medication works for you:

Starting weight and BMI

Patients with higher starting BMIs often see faster early weight loss in absolute pounds, though percentage loss tends to be similar across the range.

Dose reached

Patients who tolerate faster titration and reach the maximum dose sooner tend to see results earlier. Slower titration (to manage side effects) delays the therapeutic peak but produces similar long-term outcomes.

Dietary and lifestyle changes

Clinical trials combine semaglutide with dietary counseling and physical activity recommendations. Patients who make meaningful lifestyle changes alongside medication consistently see better results than those relying on medication alone.

Genetics and gut hormone response

GLP-1 receptor sensitivity varies between individuals. A small percentage of patients are genuine non-responders — their providers will identify this and discuss alternatives.

The bottom line

Semaglutide works — but it's not a fast fix. Appetite changes come in the first week. Meaningful weight loss builds through months 1–6. Full effect requires reaching and tolerating therapeutic doses. And the long-term evidence, including 2-year STEP trial data and 4-year SELECT data, shows that results can be sustained.

The most important thing you can do is stay on your provider's titration schedule, communicate about side effects, and give the medication the full runway it needs. Weight loss with GLP-1s is a long game — and the clinical data shows it's worth playing.

Frequently asked questions

How long does it take for semaglutide to work?

Semaglutide begins working within days — reaching peak concentration in 1–3 days after your first injection. Most patients notice reduced appetite within the first week. Measurable weight loss typically begins within 4 weeks, with the most significant progress occurring between months 3–6 as doses increase.

How much weight can you lose in the first month on semaglutide?

Clinical trial data suggests patients lose an average of about 2% of body weight per month during the first six months. For someone weighing 200 lbs, that's roughly 4 lbs in the first month. Individual results vary based on starting dose, diet, exercise, and individual biology.

When does semaglutide start suppressing appetite?

Most patients notice appetite suppression within the first few days to two weeks — feeling fuller sooner, reduced cravings, and quieter food noise. The effect strengthens as doses increase over the titration schedule.

What if semaglutide isn't working after 4 weeks?

The starting dose of 0.25mg is intentionally below therapeutic levels to minimize side effects — it's not designed to produce significant weight loss on its own. If you're not seeing any appetite changes by weeks 4–8 even at higher doses, contact your provider to discuss your titration schedule.

How long does it take to lose 20 lbs on semaglutide?

For someone at 200 lbs, a 10% loss (20 lbs) typically takes 4–6 months based on STEP trial averages. Results vary significantly based on dose reached, lifestyle factors, and individual biology. The STEP 1 trial showed average weight loss of ~15% over 68 weeks.

Does semaglutide work for tirzepatide too — is the timeline similar?

Tirzepatide follows a similar general timeline but tends to produce faster early results and greater overall weight loss. The 2.5mg starting dose of tirzepatide is also below therapeutic levels. Most patients notice meaningful appetite suppression within 2–4 weeks and significant weight loss by month 3.

† This article is for educational purposes only and does not constitute medical advice. Statistics referenced are from published clinical trials and represent group averages — individual results vary significantly. Always consult a qualified, licensed healthcare provider before starting, stopping, or changing any treatment plan. Compounded medications available through Ondra Health are not FDA-approved.

ONDRA HEALTH

Start seeing results — from $96/mo

✔

3-minute clinician-reviewed intake

✔

Provider-guided dose titration

✔

Ongoing support at every milestone

✔

Free shipping, no hidden fees

Start your intake →

Only charged if a provider approves your treatment.

Ondra Health

Personalized GLP-1 treatment plans, guided by licensed providers who care about your journey.

Verify Approval for www.ondra.health
Flexible payments with
Klarna Affirm Afterpay

Navigate

Home About Patient Portal Referral Program Contact Us

Treatments

Semaglutide Tirzepatide Semaglutide by State Tirzepatide by State Service Areas

Tools

BMI & Weight Loss GLP-1 Eligibility Weight Loss Timeline Calorie Calculator Protein & Water Semaglutide Dose Calculator Tirzepatide Dose Calculator

Resources

FAQ Blog GLP-1 Reference Pharmacy Partners

Legal

Terms of Service Privacy Policy Refund Policy HIPAA Policy Important Safety Information

© 2026 Ondra Health Inc. All rights reserved.

Ondra Health provides access to telehealth services and compounded medications through licensed providers and pharmacies.